Universal-Beteiligungs- und Servicegesellschaft
IOVA icon

Universal-Beteiligungs- und Servicegesellschaft’s Iovance Biotherapeutics IOVA Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$56.3K Sell
16,029
-17,328
-52% -$55.4K ﹤0.01% 2043
2025
Q4 		$91.1K Buy
33,357
+20,758
+165% +$48K ﹤0.01% 2024
2025
Q3 		$27.3K Buy
+12,599
New +$29.8K ﹤0.01% 2081
2025
Q2 		– Sell
-17,191
Closed -$57.2K – 2057
2025
Q1 		$57.2K Buy
+17,191
New +$88.7K ﹤0.01% 1969

Other funds holding IOVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's IOVA Position: Q1 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Iovance Biotherapeutics (IOVA) stake by 52% in Q1 2026, selling an estimated $55.4K and leaving 16,029 shares worth $56.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2043.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in IOVA in Q1 2025 and has held it in 4 quarters since. The position peaked at $91.1K in Q4 2025. 285 funds tracked by Wall St. Rank hold IOVA as of Q1 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 16,029 shares of Iovance Biotherapeutics worth $56.3K as of Q1 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 17,328 Iovance Biotherapeutics shares in Q1 2026, an estimated $55.4K.
  • Iovance Biotherapeutics made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q1 2026, its #2043 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Iovance Biotherapeutics in Q1 2025 and has held it in 4 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Iovance Biotherapeutics position peaked at $91.1K in Q4 2025.
  • 285 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q1 2026, filed 11 May 2026.